Skip to content

BioLife Solutions BLFS Net Investment in Lease

Net Investment in Lease at other companies

Danaher logo
DanaherDHR
Azenta logo
AzentaAZTA
LeMaitre Vascular logo
LeMaitre VascularLMAT
TEC
Bio-TechneTECH
CryoPort, Inc. logo
CryoPort, Inc.CYRX
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.34B+33.1%
Enterprise value$1.34B+38.1%
P/S13.5×+0.6×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's net investment in lease?
BioLife Solutions (BLFS) reported net investment in lease of $7.11M in Q1 2026.
How has BioLife Solutions's net investment in lease changed year-over-year?
BioLife Solutions's net investment in lease decreased by 29.8% year-over-year, from $10.13M to $7.11M.
What is the long-term trend for BioLife Solutions's net investment in lease?
Over 5 years (2020 to 2025), BioLife Solutions's net investment in lease has grown at a -5.1% compound annual growth rate (CAGR), from $9.68M to $7.47M.